• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较伴有和不伴有肿瘤内纤维化的胰腺神经内分泌肿瘤患者在动态增强 CT 上的强化模式和生存情况。

A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.

机构信息

Department of Radiology and the Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.

Department of Radiology, Ansan Hospital, Korea University College of Medicine, 516, Gojan 1-dong, Danwon-gu, Ansan-Si, 15355, Gyeonggi, South Korea.

出版信息

Abdom Radiol (NY). 2017 Dec;42(12):2835-2842. doi: 10.1007/s00261-017-1212-6.

DOI:10.1007/s00261-017-1212-6
PMID:28624923
Abstract

PURPOSE

To compare CT findings and survival between patients with pancreatic neuroendocrine tumors (pNETs) with and without fibrosis.

METHODS

Forty-five pNET patients with intratumoral fibrosis (group A) were matched for age, gender, and tumor size and grade with 45 pNET patients without (group B), and CT images were retrospectively reviewed. Hounsfield units (HUs) of tumors in unenhanced, arterial and portal phases, HU ratio (tumor to normal parenchyma) in each phase, enhancement patterns, visible enhancement pattern changes, and survival were compared.

RESULTS

Group A showed progressive enhancement patterns, while group B showed early enhancement and wash-out patterns (p < 0.05). HUs of tumors and HU ratio in the unenhanced phase were significantly higher in group A than group B (p ≤ 0.024), whereas those in the arterial phase were significantly lower in group A than group B (p ≤ 0.003). Peripheral to full or peripheral to peripheral enhancement change was more frequent in group A, while full to full enhancement change was more frequent in group B (p < 0.05). Group A showed significantly lower overall survival than group B (p = 0.029).

CONCLUSIONS

pNETs with fibrosis showed a progressive enhancement pattern and worse overall survival than pNETs without, which showed an early enhancement and wash-out pattern.

摘要

目的

比较伴有和不伴有纤维化的胰腺神经内分泌肿瘤(pNET)患者的 CT 表现和生存情况。

方法

将 45 例伴有肿瘤内纤维化的 pNET 患者(A 组)与 45 例无纤维化的 pNET 患者(B 组)按年龄、性别和肿瘤大小及分级进行匹配,并回顾性分析 CT 图像。比较两组患者肿瘤的平扫、动脉期和门静脉期的 CT 值(HU)、各期的肿瘤与正常实质的 HU 比值、强化模式、可见强化模式的变化以及生存情况。

结果

A 组表现为渐进性强化模式,而 B 组表现为早期强化和廓清模式(p<0.05)。A 组肿瘤的平扫 HU 值和 HU 比值均显著高于 B 组(p≤0.024),而动脉期 HU 值显著低于 B 组(p≤0.003)。A 组更常见外周至全周或外周至部分强化改变,而 B 组更常见全周至全周强化改变(p<0.05)。A 组的总体生存率显著低于 B 组(p=0.029)。

结论

与无纤维化的 pNET 相比,伴有纤维化的 pNET 表现为渐进性强化模式和更差的总体生存率,而无纤维化的 pNET 表现为早期强化和廓清模式。

相似文献

1
A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.比较伴有和不伴有肿瘤内纤维化的胰腺神经内分泌肿瘤患者在动态增强 CT 上的强化模式和生存情况。
Abdom Radiol (NY). 2017 Dec;42(12):2835-2842. doi: 10.1007/s00261-017-1212-6.
2
Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.动态对比增强计算机断层扫描中含等密度或低密度区域的胰腺神经内分泌肿瘤:影像表现谱及病理分级
Eur J Radiol. 2015 Nov;84(11):2103-9. doi: 10.1016/j.ejrad.2015.08.014. Epub 2015 Aug 22.
3
Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.非富血供胰腺神经内分泌肿瘤:MDCT 成像表现谱及与胰腺导管腺癌的鉴别诊断。
Eur J Radiol. 2019 Jan;110:66-73. doi: 10.1016/j.ejrad.2018.04.006. Epub 2018 Apr 11.
4
Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.应用动态增强 CT 对胰腺神经内分泌癌和高分化神经内分泌肿瘤进行比较。
Eur Radiol. 2020 Sep;30(9):4772-4782. doi: 10.1007/s00330-020-06867-w. Epub 2020 Apr 28.
5
Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.胰腺神经内分泌肿瘤的 CT 增强纹理分析:与 WHO 分级的相关性。
Abdom Radiol (NY). 2019 Feb;44(2):576-585. doi: 10.1007/s00261-018-1763-1.
6
Distinguishing pancreatic solid serous cystadenomas from nonfunctional pancreatic neuroendocrine tumors by computed tomography: A propensity score analysis.基于倾向评分分析的 CT 鉴别胰腺实性浆液性囊腺瘤与无功能性胰腺神经内分泌肿瘤
Medicine (Baltimore). 2022 Sep 16;101(37):e30523. doi: 10.1097/MD.0000000000030523.
7
Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?磁共振成像(MR)和计算机断层扫描(CT)检查结果的组合对于确定胰腺神经内分泌肿瘤的肿瘤分级是否有用?
Jpn J Radiol. 2017 May;35(5):242-253. doi: 10.1007/s11604-017-0627-x. Epub 2017 Mar 3.
8
Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.MDCT 分级 3 胰腺神经内分泌肿瘤:建立诊断模型并与胰腺导管腺癌的生存情况进行比较。
AJR Am J Roentgenol. 2020 Aug;215(2):390-397. doi: 10.2214/AJR.19.21921. Epub 2020 May 20.
9
Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.基于 CT 特征和纹理分析预测胰腺神经内分泌肿瘤分级。
AJR Am J Roentgenol. 2018 Feb;210(2):341-346. doi: 10.2214/AJR.17.18417. Epub 2017 Nov 15.
10
Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.胰腺神经内分泌肿瘤:利用CT表现和计算机纹理分析预测肿瘤分级
Acta Radiol. 2018 Apr;59(4):383-392. doi: 10.1177/0284185117725367. Epub 2017 Aug 2.

引用本文的文献

1
Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.基于 CT 的影像组学对 1-2 级胰腺神经内分泌肿瘤的预后价值。
Cancer Imaging. 2024 Feb 23;24(1):28. doi: 10.1186/s40644-024-00673-z.
2
Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.胰腺神经内分泌肿瘤:基于超声图像的放射组学模型预测肿瘤分级。
Br J Radiol. 2023 Sep;96(1149):20220783. doi: 10.1259/bjr.20220783. Epub 2023 Jul 26.
3
Qualitative imaging features of pancreatic neuroendocrine neoplasms predict histopathologic characteristics including tumor grade and patient outcome.
胰腺神经内分泌肿瘤的定性成像特征可预测组织病理学特征,包括肿瘤分级和患者预后。
Abdom Radiol (NY). 2022 Dec;47(12):3971-3985. doi: 10.1007/s00261-022-03430-7. Epub 2022 Feb 15.
4
Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.门静脉期增强 CT 纹理分析在胰腺导管腺癌与胰腺神经内分泌肿瘤鉴别诊断中的互补作用。
Abdom Radiol (NY). 2020 Mar;45(3):750-758. doi: 10.1007/s00261-020-02406-9.
5
What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?2017 年世界卫生组织分类和第 8 版美国癌症联合委员会胰腺神经内分泌肿瘤分期系统有哪些新内容?
Korean J Radiol. 2019 Jan;20(1):5-17. doi: 10.3348/kjr.2018.0040. Epub 2018 Dec 27.